EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis

Dmitri I Kotov, Ophelia V Lee, Stefan A Fattinger, Charlotte A Langner, Jaresley V Guillen, Joshua M Peters, Andres Moon, Eileen M Burd, Kristen C Witt, Daniel B Stetson, David L Jaye, Bryan D Bryson und 1 weitere

Cell · 2023-12 · 186 (25) · 5536-5553.e22

DOI: 10.1016/j.cell.2023.11.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-12. Verfasst von Dmitri I Kotov und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, CA 94720, USA; Howard Hughes Medical Institute, Universi…. Hauptthemen laut MEDLINE: Interferon Type I, Tuberculosis. Die Arbeit wurde bisher 169-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Howard Hughes Medical Institute, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Type ITuberculosisHumansMiceAnimalsMacrophagesCytokinesNeutrophilsDendritic Cells

Stichwörter der Autor:innen

Mycobacterium tuberculosisinnate immunologyinterstitial macrophageslungmiceneutrophil extracellular trapsneutrophilsplasmacytoid dendritic cellstype I interferons

Substanzen

Interferon Type ICytokines

Autor:innen und Institutionen

  • Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, CA 94720, USA; Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720, USA. Electronic addres…
  • Division of Immunology and Molecular Medicine, University of California, Berkeley, Berkeley, CA 94720, USA.
  • Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Ragon Institute of Mass General, MIT, and Harvard, Cambridge, MA 02139, USA.
  • Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA 30322, USA.
  • Department of Immunology, University of Washington, Seattle, WA 98195, USA.

Förderung

  • NIAID NIH HHS
  • Howard Hughes Medical Institute
  • NHLBI NIH HHS
  • European Molecular Biology Organization
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • University of California Berkeley
  • National Institutes of Health

Zitieren

APA

Kotov, D. I., Lee, O. V., Fattinger, S. A., Langner, C. A., Guillen, J. V., Peters, J. M., Moon, A., Burd, E. M., Witt, K. C., Stetson, D. B., Jaye, D. L., Bryson, B. D., & Vance, R. E. (2023). Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell, 186(25), 5536-5553.e22. https://doi.org/10.1016/j.cell.2023.11.002

Vancouver

Kotov DI, Lee OV, Fattinger SA, Langner CA, Guillen JV, Peters JM, et al. Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis. Cell. 2023;186(25):5536-5553.e22. doi:10.1016/j.cell.2023.11.002

BibTeX
@article{Kotov2023,
  author = {Kotov, Dmitri I and Lee, Ophelia V and Fattinger, Stefan A and Langner, Charlotte A and Guillen, Jaresley V and Peters, Joshua M and Moon, Andres and Burd, Eileen M and Witt, Kristen C and Stetson, Daniel B and Jaye, David L and Bryson, Bryan D and Vance, Russell E},
  title = {Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {25},
  pages = {5536--5553.e22},
  doi = {10.1016/j.cell.2023.11.002}
}
Kostenlos starten →